#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2562	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2447	310.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1641	1641	C	416	C	351	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4024	326.8	0	.	n	.	0	T695C	SNP	695	695	T	1256	1256	C	332	C	277	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4024	326.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1898	1898	A	406	A	352	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4024	326.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2532	2532	C	364	C	306	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4024	326.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3158	3158	T	412	T,C	268,76	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4024	326.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2606	2606	A	383	A,C	323,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	426	folP	852	852	100.0	folP.l15.c4.ctg.1	1952	65.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1212	1214	AGC	108;108;109	A;G;C	93;92;90	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	852	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3849	66.4	1	SNP	p	S91F	0	.	.	271	273	TCC	750	752	TCC	61;60;60	T;C;C	54;53;53	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	852	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3849	66.4	1	SNP	p	D95G	0	.	.	283	285	GAC	762	764	GAC	59;58;58	G;A;C	54;51;50	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	852	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3849	66.4	1	SNP	p	D95N	0	.	.	283	285	GAC	762	764	GAC	59;58;58	G;A;C	54;51;50	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	330	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1635	60.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	634	636	ACC	96;96;95	A;C;C	76;73;75	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	330	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1635	60.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	649	651	CAC	95;94;94	C,A;A;C	74,1;74;75	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	330	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1635	60.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	832	834	CAC	106;105;103	C;A;C	93;93;88	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	330	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1635	60.2	1	SNP	p	G45D	0	.	.	133	135	GGC	652	654	GGC	94;94;94	G;G;C	74;74;74	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	238	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1329	53.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	822	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3473	71.0	1	SNP	p	D86N	0	.	.	256	258	GAC	827	829	GAC	108;108;109	G;A;C,A	87;86;87,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	822	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3473	71.0	1	SNP	p	S87I	0	.	.	259	261	AGT	830	832	AGT	109;109;109	A;G;T	88;90;86	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	822	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3473	71.0	1	SNP	p	S87W	0	.	.	259	261	AGT	830	832	AGT	109;109;109	A;G;T	88;90;86	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	822	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3473	71.0	1	SNP	p	S87R	0	.	.	259	261	AGT	830	832	AGT	109;109;109	A;G;T	88;90;86	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	822	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3473	71.0	1	SNP	p	S88P	0	.	.	262	264	TCC	833	835	TCC	108;108;109	T;C;C	85;88;88	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	726	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3193	68.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1841	1843	GGC	83;84;83	G;G;C	72;72;68	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1500	1502	GCA	109;108;110	G;C;A	91;91;93	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1503	1505	ATC	111;111;111	A;T;C	94;92;94	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1515	1517	GTG	114;114;113	G;T;G	93;93;93	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1515	1517	GTG	114;114;113	G;T;G	93;93;93	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2019	2021	ACC	74;75;75	A;C;C	62;64;65	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2073	2075	GCG	76;76;76	G;C;G	64;61;60	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2073	2075	GCG	76;76;76	G;C;G	64;61;60	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2196	2198	GGC	72;72;72	G;G;C	57;57;55	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2205	2207	GGC	74;74;73	G;G;C	54;56;56	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	640	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	67.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2223	2225	CCG	72;73;72	C,T;C,A;G	52,1;58,1;56	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	864	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3564	72.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1800	1802	CTG	92;92;92	C,G;T,C;G	71,1;70,1;73	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	468	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2203	63.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	803	803	C	82	C	69	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	52	porB1a	984	295	90.97	porB1a.l15.c4.ctg.1	1226	11.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	956	958	AAT	9;9;9	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	52	porB1a	984	295	90.97	porB1a.l15.c4.ctg.1	1226	11.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	959	961	AAT	9;9;9	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	52	porB1a	984	295	90.97	porB1a.l15.c4.ctg.1	1226	11.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	983	985	GCA	8;8;8	G;C;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	52	porB1a	984	295	90.97	porB1a.l15.c4.ctg.1	1226	11.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1006	1008	GTA	8;7;7	G;T;A	7;7;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	52	porB1a	984	295	90.97	porB1a.l15.c4.ctg.1	1226	11.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1015	1015	A	7	A	7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	595	597	GTT	70;69;70	G,A;T;T	61,1;59;62	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	0	.	p	.	0	I75V	NONSYN	223	225	ATT	685	687	GTT	82;82;82	G,A;T;T	68,2;70;67	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	0	.	p	.	0	S89T	NONSYN	265	267	AGC	727	729	ACC	75;76;76	A,C;C,G;C	66,1;68,1;67	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	0	.	p	.	0	I98V	NONSYN	292	294	ATC	754	756	GTC	73;73;73	G,A;T;C	64,1;63;65	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	1	SNP	p	G120K	1	.	.	358	360	AAG	820	822	AAG	86;86;86	A,C;A;G	72,1;76;70	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	1	SNP	p	N121D	0	.	.	361	363	AAC	823	825	AAC	86;87;87	A;A;C,A	73;76;74,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	408	porB1b	1038	1038	99.52	porB1b.l6.c4.ctg.1	1920	63.3	1	SNP	p	A121N	1	.	.	361	363	AAC	823	825	AAC	86;87;87	A;A;C,A	73;76;74,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1632	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5377	90.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2263	2265	AAT	72;72;71	A;A;T	65;62;63	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	252	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1481	51.1	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	105;105;104	A;T;G	87;86;86	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
